Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
Xingzhi Li, Xiaobo Wang, Tao Bai, Jie Chen, Shaolong Lu, Tao Wei, Zhihong Tang, Guilin Zhao, Huaze Lu, Le‐Qun Li, Feixiang Wu
Topics & Concepts
MedicineLenvatinibHepatocellular carcinomaPropensity score matchingIncidence (geometry)Transcatheter arterial chemoembolizationInternal medicineObservational studyGastroenterologySurgeryUrologyOncologySorafenibOpticsPhysicsHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesOrgan Transplantation Techniques and Outcomes